National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
Testicular Cancer Screening (PDQ®)     
Last Modified: 04/03/2008
Health Professional Version
Summary of Evidence

Benefits
Harms

Note: Separate PDQ summaries on Testicular Cancer Treatment 1 and Levels of Evidence for Cancer Screening and Prevention Studies 2 are also available.

Benefits

Based on fair evidence, screening for testicular cancer would not result in an appreciable decrease in mortality, in part because therapy at each stage is so effective.

Harms

Based on fair evidence, screening for testicular cancer would result in unnecessary diagnostic procedures with attendant morbidity.

Description of the Evidence

  • Study Design: Opinions of respected authorities based on clinical experience, descriptive studies, or reports of expert committees.
  • Internal Validity: Not applicable.
  • Consistency: Not applicable.
  • Direction and Magnitude of Effect: Fair evidence of no reduction in mortality; good evidence for rare but serious harms.


Table of Links

1http://www.cancer.gov/cancertopics/pdq/treatment/testicular/HealthProfessional
2http://www.cancer.gov/cancertopics/pdq/screening/levels-of-evidence/HealthProfe
ssional